Trigen Laboratories is recalling approximately 10,448 100-count bottles of Methylphenidate Hydrochloride (the generic version of Concerta) 36mg Extended-release Tablets. The medication is being recalled because it failed dissolution specifications during testing. This means the tablets may not release the active ingredient into the body at the correct speed or concentration, which could affect the drug's performance.
If the medication does not dissolve as intended, a patient might receive too much or too little of the drug at one time. This could lead to a lack of effectiveness in managing ADHD symptoms or an increased risk of side effects from the stimulant medication.
You have 2 options:
Rx Only; Recall #: D-0579-2024; Quantity: 10,448 bottles
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.